ADIPOGENIX, INC.

Basic Information

ADIPOGENIX, INC.
801 ALBANY ST, S112
BOSTON, MA, 02119 0251

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. New Agents That Inhibit Fatty Acid Accumulation

    Amount: $723,344.00

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Existing treatments for obesity are only ...

    SBIR Phase II 2004 Department of Health and Human Services
  2. New Agents That Inhibit Fatty Acid Accumulation

    Amount: $99,894.00

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Although weight loss is the most effectiv ...

    SBIR Phase I 2003 Department of Health and Human Services
  3. Activators of Adipocyte Fatty Acid Oxidation

    Amount: $99,944.00

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Existing drug and dietary treatments for ...

    SBIR Phase I 2003 Department of Health and Human Services
  4. SECRETED PROTEIN FROM ADIPOCYTES AND PREADIPOCYTES

    Amount: $99,820.00

    DESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. While weight loss is the most effective t ...

    SBIR Phase I 2002 Department of Health and Human Services
  5. Anti-obesity drug development using human preadipocytes

    Amount: $0.00

    N/A

    SBIR Phase I 2001 Department of Health and Human Services
  6. Anti-obesity drug development using human preadipocytes

    Amount: $602,471.00

    N/A

    SBIR Phase II 2001 Department of Health and Human Services
  7. N/A

    Amount: $99,930.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  8. ENHANCED DIFFERENTIATION OF HUMAN PREADIPOCYTES

    Amount: $99,972.00

    Not Available The objective of Phase I is to develop and demonstrate a neural networks system to predict, map, and interpolate rotorcraft ground noise exposure data. It is well-known that the relat ...

    SBIR Phase I 1999 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government